Clinical TrialID 1237
Echinacea and Acute Respiratory Illness
NCT02003651
Acute Respiratory Infections
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 1237
- Evidence Id
- 1237
- Core Evidence Id
- 1237
- Source Clinical Trial Id
- 1220
- Herb2 Clinical Trial Id
- HBCT001220
- Nct Id
- NCT02003651
- Title
- Echinacea and Acute Respiratory Illness
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Acute Respiratory Infections
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
- Intervention
- DIETARY_SUPPLEMENT: Quick Defense|DIETARY_SUPPLEMENT: Placebo
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Prevention
- Gender
- Female
- Age
- Adult
- Enrollment
- 40
- Outcome Measure
- Common cold symptoms, The Wisconsin Upper Respiratory Symptom Survey (WURSS-24) will be used to assess common cold illness severity and symptoms (see attached questionnaire). Subjects will fill in the one-page WURSS-24 at the end of each day during the 12-week monitoring period. This 12-week period will cover the winter and early spring period of 2014. From the responses recorded during the 84-day study, an ARI severity score will be calculated by summing the daily ARI global severity score (0=not sick, 1=very mild ARI to 7=severe). The ARI symptom score for the 84-day period will be calculated by summing all 10 symptom scores for each day's entry (0=do not have this symptom, 1=very mild to 7=severe). In similar fashion, the ARI function ability score for the 84-day period will be calculated by summing all 9 function scores for each day's entry (0=do not have this symptom, 1=very mild to 7=severe). Separate scores will be calculated comparing groups for each illness episode recorded by the subjects., 12-weeks
- Sponsor Collaborator
- Appalachian State University|Gaia Herbs Inc.
- Funded By
- OTHER
- Location
- ASU-NCRC Human Performance Lab, Kannapolis, North Carolina, 28081, United States
- Other Id
- 14-0064
- Start Date
- 2013-11
- Primary Completion Date
- 2014-04
- Completion Date
- 2014-08
- First Posted
- 2013-12-06
- Results First Posted
- Last Update Posted
- 2016-12-13
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT02003651
- Title Cn
- Title En
- Echinacea and Acute Respiratory Illness
- Bilingual Status
- semi_complete